News from NYU Langone Health
NYU Langone Manhattan tops healthcare ranking for fifth year in a row
New York Post
NYU Langone Health’s Manhattan campus was named the top comprehensive academic medical center in the nation by Vizient for the fifth consecutive year. The ranking bested over 120 institutions based on metrics including safety, mortality, and effectiveness. Alec Kimmelman, MD, PhD, dean of NYU Grossman School of Medicine and CEO of NYU Langone Health, credited the achievement to the staff's commitment to high standards. NYU Langone's network of ambulatory practices was also ranked highest among 70 participating organizations, while inpatient facilities in Brooklyn and on Long Island also earned honors.
9/24/2026
He changed the world of organ transplants. Would he die waiting for his own?*
The New York Times
The New York Times profiles Robert Montgomery, MD, PhD, the H. Leon Pachter, MD, Professor of Surgery and chair of the Department of Surgery at NYU Grossman School of Medicine, and director of the NYU Langone Transplant Institute. The article details his personal battle with a genetic heart condition that led to him receiving a heart transplant at NYU Langone Health in 2018. It highlights his pioneering work, including developing innovative kidney swap programs and leading the team at NYU Langone Health that performed the first transplant of a genetically modified pig kidney into a human in 2021. Dr Montgomery is currently leading clinical trials for pig organ transplants at the institution.
9/23/2026
These scientists are charting a new future for organ transplantation—and it starts with pigs
Gizmodo
Researchers at the NYU Langone Transplant Institute are the winners of the 2026 Gizmodo Science Fair for their ongoing work in developing animal-to-human transplantation, also known as xenotransplantation.
9/24/2026
How Dr. Joseph Zuckerman is scaling NYU Langone Orthopedics
Becker's Spine Review
Joseph Zuckerman, MD, chair of orthopedic surgery at NYU Langone Health, discusses the department's rapid expansion and the strategic recruitment of three high-profile surgeons: Dr. Sabrina Strickland, Dr. Andreas Gomoll, and Dr. F. Winston Gwathmey. As NYU Langone scales its footprint—including the expansion of its Manhattan center and planned facilities in Suffolk and Westchester counties—Dr. Zuckerman emphasizes that cultural fit and collaborative alignment matter more than case volume alone. By building dedicated centers for joint preservation and directing surgeons to focus on patient outcomes, the department aims to expand specialized care without becoming fragmented.
9/23/2026
Yankees not expecting Aaron Judge for AL wild-card series in massive blow
New York Post
New York Yankees player Aaron Judge is expected to miss the start of the playoffs with a moderate calf strain. Daniel Kaplan, MD, a sports orthopedic surgeon at NYU Langone Health, who has not treated Judge, commented that a moderate strain is typically Grade 2 and involves a three- to six-week recovery. Dr. Kaplan also explained that Judge's platelet-poor plasma injection was likely intended to reduce inflammation for a faster return. He noted that Judge could potentially come back sooner if he is able to serve as a designated hitter.
Also reporting was: MSN UK
9/22/2026
ABC 7 Sports Desk
Daniel Kaplan, MD, sports orthopedic surgeon at NYU Langone Health, discussed the next steps for Washington Commanders quarterback Jayden Daniels after he suffered his second left elbow dislocation in less than a year. Dr. Kaplan explained that evaluating the quarterback requires an MRI and potentially an examination under anesthesia with X-rays to assess joint stability. He noted that because this is a recurring injury, the threshold for recommending surgery is now significantly lower than it was initially, though specialists are still weighing whether a non-surgical rehab path remains viable.
9/23/2026
Dr. Michael Alaia details Jayden Daniels elbow & possible recommendation for surgery
106.7 The Fan
Michael Alaia, MD, sports orthopedic surgeon at NYU Langone Health, discussed Jayden Daniels's second elbow dislocation. He said: "My worry is that if this doesn't get stabilized, this might be more of a recurring type injury.. Bracing has been shown to help unstable injuries.. Sometimes surgery is indicated."
Also reporting was: Riggo's Rag
9/22/2026
Alopecia areata treatment: Medication, platelet-rich plasma, and more
Everyday Health
Common treatments for alopecia areata include oral medications, topical therapies, and injections, according to Kristen Lo Sicco, MD, dermatologist at NYU Langone Dermatologic Associates, chief of service and director of the Skin and Cancer Unit at NYU Langone Health. The article explains that oral options like immunosuppressants and Janus Kinase (JAK) inhibitors work by reducing the immune system's attack on hair follicles. Topical therapies such as corticosteroids, minoxidil, and immunotherapy are applied directly to the skin to stimulate regrowth. The piece also notes that injectable corticosteroids can be administered into affected areas to suppress local immune cells and allow hair to regrow.
9/23/2026
Immune reconstitution after fixed-duration venetoclax-based therapy
OncLive
The article reviews immune recovery timelines after fixed-duration venetoclax-based therapy for chronic lymphocytic leukemia. Marc Braunstein, MD, PhD, associate professor of medicine at NYU Grossman Long Island School of Medicine, advises that patients are not out of the woods post-treatment. He notes that obinutuzumab can delay B-cell recovery for years, and his team tells patients to report any infectious symptoms, expecting infection risk to meaningfully fall only after six to 12 months.
9/23/2026
Dr Lepor on rise of precision strategies to address early prostate cancer
Targeted Oncology
In an interview, Herbert Lepor, MD, the Martin Spatz Chairman of the Department of Urology and professor of urology and biochemistry and molecular pharmacology at NYU Grossman School of Medicine, discussed the evolution of localized prostate cancer management. He highlighted the growing role of MRI-guided biopsies, the evidence supporting active surveillance for low-risk disease, and the judicious use of genetic testing. Dr. Lepor also detailed outcomes from focal therapy, an organ-preserving alternative he helped pioneer at NYU Langone Health's Perlmutter Cancer Center, noting it significantly reduces morbidity while providing effective cancer control.
9/23/2026
Something in your eye? Here’s how to get it out – without making it worse
The Guardian
Experts advise on safely removing foreign objects from the eye to avoid infection or corneal scratches. Douglas Lazzaro, MD, a professor of ophthalmology and vice chair of clinical affairs and business development for the Department of Ophthalmology at NYU Langone Health, notes that common culprits include eyelashes, dust, and glue from false eyelashes. While blinking and artificial tears can often flush out small objects, Dr. Lazzaro recommends seeking professional help if irrigation fails. Other experts warn against rubbing the eye, using tools like tweezers at home, or touching the eye with fingers, as these actions can cause further injury or introduce bacteria.
Also reporting was: Yahoo Health, AOL UK
9/23/2026
250 best healthcare employers: Forbes
Becker's Hospital Review
Forbes named 250 organizations to its second annual list of America’s Best Employers for Healthcare Professionals, ranking NYU Langone Health at No. 66. The list, created with market research firm Statista, was based on a survey of over 30,000 employees at U.S. healthcare providers. Several other New York City-based competitors were also included, such as Memorial Sloan Kettering Cancer Center at No. 19, Hospital for Special Surgery at No. 35, Northwell Health at No. 52, NewYork-Presbyterian Hospital at No. 77, and Mount Sinai Health System at No. 181.
9/23/2026
Coffee vs. tea: Which is better for bone health?
Health
Research suggests tea may be more beneficial for bone health than coffee, as studies link tea consumption to higher bone density in older women. In contrast, very high coffee intake has been associated with lower bone density. Rachel Pessah-Pollack, MD, an endocrinologist at NYU Langone Health, states that beverage choice is a minor factor for bone health. She emphasizes that more important considerations include getting enough calcium and vitamin D, performing regular strength training, limiting alcohol consumption, and avoiding smoking.
Also reporting was: Aol, MSN UK
9/23/2026
Continuous glucose monitoring alert settings and glycemic control in people with diabetes
JAMA Network
A retrospective cohort study, approved by the institutional review board at NYU Langone Health, examined the association between continuous glucose monitoring (CGM) alert settings and glycemic control in 2,387 participants with diabetes. Findings suggest that enabling high and low glucose alerts is linked to better glycemic outcomes. Specifically, setting more aggressive high-glucose alert thresholds was associated with more favorable profiles, including higher time-in-range. The authors conclude that these findings support further evaluation of individualized CGM alert settings to improve patient safety and glycemic outcomes.
9/23/2026
Dermatology roundup: Genetic link between GLP-1 receptor agonists and hair loss
Journal of Drugs in Dermatology
A new study led by researchers at NYU Langone Health provides the first scientific evidence of a genetic link between GLP-1 receptor agonists and hair loss. The research found that men with androgenetic alopecia have a 7% greater likelihood of experiencing hair loss from these medications due to specific genes. Lynn Petukhova, PhD, assistant professor in the Ronald O. Perelman Department of Dermatology and the Department of Population Health at NYU Grossman School of Medicine, stated the findings could lead to screening patients for hair loss risk before they are prescribed GLP-1 medications.
9/23/2026
Oshkosh Northwestern
The Choroideremia Research Foundation will host a free patient and family meeting in New York City on 14 November 2026. The event, held at the SUNY College of Optometry, will connect individuals affected by choroideremia, a rare retinal disease, with resources and clinical updates. Confirmed presenters include John-Ross Rizzo, MD, the Ilse Melamid Associate Professor of Rehabilitation Medicine, vice chair of the Department of Rehabilitation Medicine, and deputy director of the Institute for Excellence in Health Equity (IEHE) at NYU Grossman School of Medicine. Other speakers represent Columbia University Medical Center and SUNY College of Optometry. The meeting will also feature organizations that support people who are blind or have low vision.
9/23/2026
$3.8M NIH grant to explore regulators of cell fate
The Pennsylvania State University (PSU)
A research team from Penn State and NYU Grossman School of Medicine has received a $3.8 million grant from the National Institutes of Health to explore how proteins called transcription factors regulate gene expression during embryonic development. The team includes Esteban Mazzoni, PhD, professor in the Departments of Cell Biology and Neuroscience, and Timothee Lionnet, PhD, associate professor in the Department of Cell Biology. They will investigate how these factors control the development of different neuron types, which could provide insights into developmental disorders and support regenerative medicine.
9/23/2026
Sage Bionetworks will build the platform that tests whether AI digital twins are ready for the ICU
Abilene Reporter-News
Sage Bionetworks received a contract award from the Advanced Research Projects Agency for Health for up to $18.3 million to build a platform called Twin-TECC. This platform will test whether AI-driven digital twin models of patients are ready for use in the ICU. The project aims to evaluate the models against FDA guidance to ensure they are trustworthy for clinical decisions and prepared for regulatory review. As the prime awardee, Sage is partnering with several multidisciplinary subawardees, including the NYU Grossman School of Medicine, InSilicoTrials Technologies, and The Jackson Laboratory.
9/23/2026
Multi-site course boosts psychiatry
SCIENMAG
A new study in Academic Psychiatry shows that a standardized six-hour curriculum can significantly improve psychiatry residents' knowledge and confidence regarding psychedelic medicine. The curriculum was tested across four residency programs in the Northeastern US. The multi-institutional study team included researchers from Johns Hopkins, NYU Grossman School of Medicine, Yale, and Columbia. Following the course, trainees demonstrated improved knowledge and greater confidence in counseling patients on clinical research, harm reduction, and treatment risks, providing a template for addressing the educational gap in this rapidly advancing field of medicine.
9/23/2026
Neurocritical Care Society issues new ethical roadmap for organ donation at the end of life
SCIENMAG
The Neurocritical Care Society has issued a new ethical guidance statement to provide clinicians with a clearer framework for organ donation following severe brain injuries. Published in the journal Neurocritical Care, the statement's senior author is Ariane Lewis, MD, professor in the Departments of Neurology and Neurosurgery and director of the Division of Neurocritical Care at NYU Langone Health. The guidance addresses key ethical areas, including legal definitions of death, first-person authorization for donation, palliative care interventions, collaborative communication with families, and managing potential conflicts of interest for care teams at the bedside.
9/23/2026
Could ‘bloomscrolling’ help improve your quality of life? What to know about the new trend
Women's Health
The article explores 'bloomscrolling,' the habit of seeking positive online content to boost one’s mood as an alternative to 'doomscrolling.' Thea Gallagher, PsyD, clinical associate professor in NYU Langone's Department of Psychiatry, explains that people have a natural negativity bias, but their behavior shapes what they see online. She notes that while positive content can improve mood, it does not negate compulsive behavior. Gallagher suggests using bloomscrolling intentionally for short periods to interrupt negative thought patterns, viewing it as a brief mood-shifting tool rather than a replacement for real-life engagement.
Also reporting was: Yahoo Health, MSN UK
9/23/2026
New statistical model maps how air pollution reshapes the human microbiome
SCIENMAG
A team of biostatisticians and clinicians at NYU Grossman School of Medicine developed a new statistical framework, SpaMixed, to more accurately analyze how air pollution reshapes the human microbiome. Published in Genome Medicine, the model addresses analytical problems that have previously undermined microbiome studies by accounting for geographic and ecological factors. The researchers demonstrated the method's utility by applying it to two studies, including one examining the lung microbiome at NYU Langone Health, to identify which microbial species respond to environmental pollutants like fine particulate matter.
9/23/2026
Motion-related repeat MRI sequences create considerable operational burden
Radiology Business
New research from the NYU Grossman School of Medicine and Siemens Healthineers indicates that motion-related repeat MRI sequences create a considerable operational burden. The study analyzed six months of MRI exams and found that approximately 5% of over 85,000 exams included at least one repeated sequence, accounting for about 115 additional scanner hours. According to corresponding author Hersh Chandarana, MD, physician-scientist and vice chair of radiology hospital operations and analytics in the Department of Radiology at NYU Grossman School of Medicine, the findings support a more targeted approach to motion mitigation, tracking diagnostic yield to reduce low-value imaging and preserve scanner capacity.
9/24/2026
1 million take Ozempic for no good reason
Newsmax
A new study in the journal 'Obesity' found that over 1.1 million U.S. adults were prescribed GLP-1 medications like Ozempic without an approved condition documented in their electronic health records. The research was led by Babak Orandi, MD, PhD, associate professor in the Departments of Surgery and Medicine at NYU Grossman School of Medicine. He noted that positive public anecdotes may be driving people's curiosity about using the drugs off-label. The analysis showed a 15-fold increase in these prescriptions from 2021 to 2025, raising concerns about potential risks for patients without obesity or diabetes.
Also reporting was: Yahoo
9/23/2026
Melanoma's genetic blueprint builds immune-proof tumor neighborhoods, study finds
SCIENMAG
A team at NYU Grossman School of Medicine discovered how a genetic mutation allows melanoma to resist immunotherapy. Published in 'Molecular Cancer ', the research led by Milad Ibrahim, postdoctoral fellow, and Markus Schober, PhD, associate professor in the Ronald O. Perelman Department of Dermatology and the Department of Cell Biology, found that losing the NF1 gene remodels the tumor's environment to block immune cells. This finding explains why some melanomas do not respond to checkpoint inhibitors. The study also suggests that blocking EGFR signaling could re-sensitize these tumors to treatment, offering a potential new combination therapy.
9/23/2026
New autism committee chair founded a leucovorin telehealth company
MedPage Today
John Gaitanis, MD, the new chair of the federal Interagency Autism Coordinating Committee (IACC), co-founded a telehealth company that provides leucovorin for children with autism, raising conflict of interest concerns. Arthur Caplan, PhD, professor emeritus of medical ethics at NYU Grossman School of Medicine, stated there is no evidence leucovorin helps with autism. He argued that promoting non-tested products should disqualify a candidate for such a role, even if they have divested financially. Caplan noted a pattern of appointments by the Trump administration with connections to 'fringe remedies'.
Also reporting was: MSN UK
9/23/2026
